Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Show more...
FAQ
Fennec Pharmaceuticals 今天的股價是多少?▼
FENC.BOATS 目前價格為 $7.54 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Fennec Pharmaceuticals 股價表現。
Fennec Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Fennec Pharmaceuticals 的股票以代號 FENC.BOATS 進行交易。
Fennec Pharmaceuticals 的市值是多少?▼
今天 Fennec Pharmaceuticals 的市值為 211.59M
Fennec Pharmaceuticals 下一次財報日期是什麼時候?▼
Fennec Pharmaceuticals 將於 May 07, 2026 公布下一次財報。
Fennec Pharmaceuticals 上一季度的財報如何?▼
FENC.BOATS 上一季度的財報為每股 -0.02 USD,預估為 -0.02 USD,帶來 +8.72% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Fennec Pharmaceuticals 去年的營收是多少?▼
Fennec Pharmaceuticals 去年的營收為 95.08MUSD。
Fennec Pharmaceuticals 去年的淨利是多少?▼
FENC.BOATS 去年的淨收益為 -872,000USD。
Fennec Pharmaceuticals 有多少名員工?▼
截至 April 01, 2026,公司共有 36 名員工。
Fennec Pharmaceuticals 位於哪個產業?▼
Fennec Pharmaceuticals從事於Health Care產業。
Fennec Pharmaceuticals 何時完成拆股?▼
Fennec Pharmaceuticals 最近沒有進行任何拆股。
Fennec Pharmaceuticals 的總部在哪裡?▼
Fennec Pharmaceuticals 的總部位於 CA 的 Research Triangle Park。